Vas Narasimhan: El médico de 42 años que pasó de tratar la malaria en Gambia a dirigir un gigante farmacéutico | Líderes
Novartis on LinkedIn: Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global… | 281 comments
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises - YouTube
Novartis CEO's take-home pay jumps 59%. But there's one miss—ethics | Fierce Pharma
Novartis CEO on how to price lifesaving cell and gene therapies
Vas Narasimhan | One Young World
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Vas Narasimhan, CEO de la farmaceútica Novartis | XLSemanal
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Performance slump takes toll on Novartis' CEO's 2022 payout
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
Vas Narasimhan Ceo Swiss Pharmaceutical Group Foto de stock de contenido editorial - Imagen de stock | Shutterstock
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company | Ceo, Development, Company
El CEO de Novartis advierte: una vacuna no bastará para combatir el COVID - Infobae
Watch Novartis CEO on Acquisitions, AI, Weight-Loss Drugs - Bloomberg
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
Novartis inicia una revisión exhaustiva de Beovu por sus efectos adversos
Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New Technology
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook
Novartis CEO refutes respiratory, eye drug sell-off rumor
Novartis CEO Vas Narasimhan on Culture, Strategy and Change
